Derma Sciences
Christine Flynn is an experienced professional in sales operations and pricing analysis. As the Sales Operations Manager at Derma Sciences since February 2013, Flynn has honed skills in operational efficiency and sales strategy. Prior to that role, Flynn served as a Sr Pricing Analyst at Ansell Healthcare from August 2006 to January 2013, developing expertise in pricing models and market analysis. Flynn holds a Bachelor of Science degree in Management and Communications as well as an MBA from Saint Peter's University, where studies continue in Business Management, Finance, and Management Information Systems.
This person is not in any teams
Derma Sciences
Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.